Seeing Is Believing

Currently out of the existing stock ratings of Myles Minter, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).
Analyst Myles Minter, currently employed at WILLIAM BLAIR, carries an average stock price target met ratio of 25% that have a potential upside of 3.62% achieved within 20 days.
Myles Minter’s has documented 18 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALEC, Alector at 22-Oct-2025.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 1/14/2020. The price target of $105 was fulfilled within 7 days with a profit of $20.13 (23.72%) receiving and performance score of 33.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 07-Mar-2025
$3
$0.92 (44.23%)
$2
Hold Since 10-Mar-2026
$6
$4.14 (222.58%)
7 months ago
(10-Mar-2026)
1/4 (25%)
$3.62 (152.10%)
70
Buy Since 24-Jun-2020
$5
$3.14 (168.82%)
$10
11 months 17 days ago
(23-Oct-2025)
0/9 (0%)
$3.53 (240.14%)
Hold Since 22-Oct-2025
11 months 19 days ago
(22-Oct-2025)
0/1 (0%)
$6.12 (88.95%)
Hold Since 22-Oct-2025
11 months 19 days ago
(22-Oct-2025)
0/1 (0%)
$9.01 (37.56%)
What Year was the first public recommendation made by Myles Minter?